After peaking at over 185,000 courses in 2015, prescriptions for direct-acting antivirals (DAAs) for hepatitis C virus infections dropped 63% by 2025. While those older than 61 years accounted for ...
Use of direct-acting antiviral (DAA) treatment (without interferon) was shown to reduce liver and nonliver complications, as well as improve long-term overall survival among patients with chronic ...
"Hepatitis C is a curable disease, but current treatment levels are substantially below what's needed to achieve national elimination targets." HealthDay News — Direct-acting antiviral (DAA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results